These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 15801839

  • 1. CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.
    Boeckler F, Ohnmacht U, Lehmann T, Utz W, Hübner H, Gmeiner P.
    J Med Chem; 2005 Apr 07; 48(7):2493-508. PubMed ID: 15801839
    [Abstract] [Full Text] [Related]

  • 2. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, Neve KA.
    J Med Chem; 1998 Oct 22; 41(22):4385-99. PubMed ID: 9784114
    [Abstract] [Full Text] [Related]

  • 3. Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.
    Elsner J, Boeckler F, Heinemann FW, Hübner H, Gmeiner P.
    J Med Chem; 2005 Sep 08; 48(18):5771-9. PubMed ID: 16134944
    [Abstract] [Full Text] [Related]

  • 4. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
    Salama I, Hocke C, Utz W, Prante O, Boeckler F, Hübner H, Kuwert T, Gmeiner P.
    J Med Chem; 2007 Feb 08; 50(3):489-500. PubMed ID: 17266201
    [Abstract] [Full Text] [Related]

  • 5. CoMFA and CoMSIA investigations of dopamine D3 receptor ligands leading to the prediction, synthesis, and evaluation of rigidized FAUC 365 analogues.
    Salama I, Schlotter K, Utz W, Hübner H, Gmeiner P, Boeckler F.
    Bioorg Med Chem; 2006 Sep 01; 14(17):5898-912. PubMed ID: 16750374
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
    Ehrlich K, Götz A, Bollinger S, Tschammer N, Bettinetti L, Härterich S, Hübner H, Lanig H, Gmeiner P.
    J Med Chem; 2009 Aug 13; 52(15):4923-35. PubMed ID: 19606869
    [Abstract] [Full Text] [Related]

  • 7. A 3D QSAR study on a set of dopamine D4 receptor antagonists.
    Boström J, Böhm M, Gundertofte K, Klebe G.
    J Chem Inf Comput Sci; 2003 Aug 13; 43(3):1020-7. PubMed ID: 12767161
    [Abstract] [Full Text] [Related]

  • 8. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH.
    Arch Pharm (Weinheim); 2004 Jul 13; 337(7):383-90. PubMed ID: 15237388
    [Abstract] [Full Text] [Related]

  • 9. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.
    Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660
    [Abstract] [Full Text] [Related]

  • 10. Dopaminergic 7-aminotetrahydroindolizines: ex-chiral pool synthesis and preferential D3 receptor binding.
    Lehmann T, Hübner H, Gmeiner P.
    Bioorg Med Chem Lett; 2001 Nov 05; 11(21):2863-6. PubMed ID: 11597417
    [Abstract] [Full Text] [Related]

  • 11. Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands.
    Ding K, Chen J, Ji M, Wu X, Varady J, Yang CY, Lu Y, Deschamps JR, Levant B, Wang S.
    J Med Chem; 2005 May 05; 48(9):3171-81. PubMed ID: 15857123
    [Abstract] [Full Text] [Related]

  • 12. New series of morpholine and 1,4-oxazepane derivatives as dopamine D4 receptor ligands: synthesis and 3D-QSAR model.
    Audouze K, Nielsen EØ, Peters D.
    J Med Chem; 2004 Jun 03; 47(12):3089-104. PubMed ID: 15163190
    [Abstract] [Full Text] [Related]

  • 13. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):36-45. PubMed ID: 17056032
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
    Zhang J, Chen X, Yu L, Zhen X, Zhang A.
    Bioorg Med Chem; 2008 Nov 01; 16(21):9425-31. PubMed ID: 18835172
    [Abstract] [Full Text] [Related]

  • 15. [Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].
    Abaimov DA, Zimin IA, Kovalev GI.
    Eksp Klin Farmakol; 2008 Nov 01; 71(1):18-21. PubMed ID: 18365481
    [Abstract] [Full Text] [Related]

  • 16. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H, Li H, Ma Q.
    J Mol Graph Model; 2007 Jul 01; 26(1):226-35. PubMed ID: 17208024
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S, Johnson JL, Regardie K, Chen R, Koprivica V, Tadori Y, Kambayashi J, Kitagawa H, Kikuchi T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):348-56. PubMed ID: 17070976
    [Abstract] [Full Text] [Related]

  • 18. Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands.
    Mach UR, Hackling AE, Perachon S, Ferry S, Wermuth CG, Schwartz JC, Sokoloff P, Stark H.
    Chembiochem; 2004 Apr 02; 5(4):508-18. PubMed ID: 15185375
    [Abstract] [Full Text] [Related]

  • 19. Fancy bioisosteres: synthesis and dopaminergic properties of the endiyne FAUC 88 as a novel non-aromatic D3 agonist.
    Lenz C, Haubmann C, Hübner H, Boeckler F, Gmeiner P.
    Bioorg Med Chem; 2005 Jan 03; 13(1):185-91. PubMed ID: 15582463
    [Abstract] [Full Text] [Related]

  • 20. Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors.
    Vendrell M, Soriano A, Casadó V, Díaz JL, Lavilla R, Canela EI, Lluís C, Franco R, Albericio F, Royo M.
    ChemMedChem; 2009 Sep 03; 4(9):1514-22. PubMed ID: 19557804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.